Skip to main content

Table 4 Correlation between the Participants Hepatitis B Knowledge and Practice

From: Management of hepatitis B infected pregnant women: a cross-sectional study of obstetricians

Knowledge   YES n(%) NO n(%) ra P
  (Q13) Referral for chronic HBV management   
(Q14) Complications of hepatitis B infection correct 80 (61.5) 50 (38.5) 0.05 0.520
incorrect 4 (50.0) 4 (50.0)
(Q18) Risk of chronic HBV infection correct 21 (60.0) 14 (40.0) −0.01 0.904
incorrect 63 (61.2) 40 (38.8)
Combination of Q14 + Q18 correct 20 (62.5) 12 (37.5) 0.02 0.831
incorrect 64 (60.4) 42 (39.6)
  (Q11) Monitoring of hepatitis B while pregnant   
(Q17) Risk of newborn developing chronic infection Correct 33 (76.7) 10 (23.3) 0.18 0.033
Incorrect 55 (57.9) 40 (42.1)
  (Q6) Vaccination, HBIG   
(Q17) Risk of newborn developing chronic infection Correct 38 (88.4) 5 (11.6) −0.03 0.700
Incorrect 86 (90.5) 9 (9.5)
  (Q7) Vaccination, Birth dose   
(Q17) Risk of newborn developing chronic infection Correct 37 (86.0) 6 (14.0) −0.03 0.697
Incorrect 84 (88.4) 11 (11.6)
  (Q8) Vaccination, completion of series   
(Q17) Risk of newborn developing chronic infection Correct 24 (55.8) 19 (44.2) 0.10 0.254
Incorrect 43 (45.3) 52 (54.7)
  (Q9) Vaccination, post vaccine serology testing   
(Q17) Risk of newborn developing chronic infection correct 10 (23.3) 33 (76.7) 0.05 0.563
incorrect 18 (18.9) 77 (81.1)
  1. aCorrelation Coefficient
  2. Boldface indicates statistical significance, defined as p-value ≤ 0.05.